Ontology highlight
ABSTRACT: Introduction
Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess the value of longitudinal self- and informant reports of cognitive decline to predict Aβ positron emission tomography (PET) outcome in cognitively unimpaired middle-aged individuals.Methods
A total of 261 participants from the ALFA+ study underwent [18F]flutemetamol PET and Subjective Cognitive Decline Questionnaire (SCD-Q) concurrently, and 3 years before scan. We used logistic regressions to evaluate the ability of SCD-Q scores (self and informant) to predict Aβ PET visual read, and repeated analysis of variance to assess whether changes in SCD-Q scores relate to Aβ status.Results
Self-perception of decline in memory (odds ratio [OR] = 1.2), and informant p
SUBMITTER: Sanchez-Benavides G
PROVIDER: S-EPMC7656171 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature